| Year |
Citation |
Score |
| 2019 |
Ha ID, Xiang L, Peng M, Jeong JH, Lee Y. Frailty modelling approaches for semi-competing risks data. Lifetime Data Analysis. PMID 30734137 DOI: 10.1007/S10985-019-09464-2 |
0.44 |
|
| 2017 |
Mamounas EP, Tang G, Paik S, Baehner FL, Liu Q, Jeong JH, Kim SR, Butler SM, Jamshidian F, Cherbavaz DB, Sing AP, Shak S, Julian TB, Lembersky BC, Lawrence Wickerham D, et al. 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology. Breast Cancer Research and Treatment. PMID 29128898 DOI: 10.1007/S10549-017-4550-8 |
0.376 |
|
| 2017 |
Blum JL, Flynn PJ, Yothers G, Asmar L, Geyer CE, Jacobs SA, Robert NJ, Hopkins JO, O'Shaughnessy JA, Dang CT, Gómez HL, Fehrenbacher L, Vukelja SJ, Lyss AP, Paul D, ... ... Jeong JH, et al. Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016714147. PMID 28398846 DOI: 10.1200/JCO.2016.71.4147 |
0.341 |
|
| 2017 |
Mamounas EP, Liu Q, Paik S, Baehner FL, Tang G, Jeong JH, Kim SR, Butler SM, Jamshidian F, Cherbavaz DB, Sing AP, Shak S, Julian TB, Lembersky BC, Wickerham DL, et al. 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy. Journal of the National Cancer Institute. 109. PMID 28122895 DOI: 10.1093/Jnci/Djw259 |
0.375 |
|
| 2016 |
Balmert L, Jeong JH. Nonparametric inference on quantile lost lifespan. Biometrics. PMID 27377773 DOI: 10.1111/Biom.12555 |
0.398 |
|
| 2015 |
Christian NJ, Ha ID, Jeong JH. Hierarchical likelihood inference on clustered competing risks data. Statistics in Medicine. PMID 26278918 DOI: 10.1002/Sim.6628 |
0.708 |
|
| 2015 |
Lim JY, Jeong JH. Cause-specific quantile residual life regression. Statistical Methods in Medical Research. PMID 26113385 DOI: 10.1177/0962280215592426 |
0.589 |
|
| 2015 |
Zakeri K, Rose BS, D'Amico AV, Jeong JH, Mell LK. Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 115: 114-9. PMID 25857696 DOI: 10.1016/J.Radonc.2015.03.018 |
0.311 |
|
| 2015 |
Gavin PG, Song N, Johnson NL, Lipchik C, Kim S, Finnigan M, Bandos H, Jeong J, Costantino JP, Rastogi P, Romond EH, Fehrenbacher L, Mamounas EP, Swain SM, Wickerham DL, et al. Abstract CT129: Association of the FCGR2A and FCGR3A genotypes with trastuzumab benefit in NSABP B-31 Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ct129 |
0.33 |
|
| 2015 |
Kim S, Gavin PG, Pogue-Geile KL, Song N, Finnigan M, Bandos H, Jeong J, Rastogi P, Romond EH, Fehrenbacher L, Mamounas EP, Swain SM, Wickerham DL, Geyer CE, Costantino JP, et al. Abstract 2837: A surrogate gene expression signature of tumor infiltrating lymphocytes (TILs) predicts degree of benefit from trastuzumab added to standard adjuvant chemotherapy in NSABP (NRG) trial B-31 for HER2+ breast cancer Cancer Research. 75: 2837-2837. DOI: 10.1158/1538-7445.Am2015-2837 |
0.37 |
|
| 2014 |
Ha ID, Lee M, Oh S, Jeong JH, Sylvester R, Lee Y. Variable selection in subdistribution hazard frailty models with competing risks data. Statistics in Medicine. 33: 4590-604. PMID 25042872 DOI: 10.1002/Sim.6257 |
0.404 |
|
| 2014 |
Ha ID, Christian NJ, Jeong JH, Park J, Lee Y. Analysis of clustered competing risks data using subdistribution hazard models with multivariate frailties. Statistical Methods in Medical Research. PMID 24619110 DOI: 10.1177/0962280214526193 |
0.717 |
|
| 2013 |
Pogue-Geile KL, Kim C, Jeong JH, Tanaka N, Bandos H, Gavin PG, Fumagalli D, Goldstein LC, Sneige N, Burandt E, Taniyama Y, Bohn OL, Lee A, Kim SI, Reilly ML, et al. Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. Journal of the National Cancer Institute. 105: 1782-8. PMID 24262440 DOI: 10.1093/Jnci/Djt321 |
0.381 |
|
| 2013 |
Park BH, Kook S, Lee S, Jeong JH, Brufsky A, Lee BC. An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration. The Journal of Biological Chemistry. 288: 28656-67. PMID 23966000 DOI: 10.1074/Jbc.M113.509505 |
0.355 |
|
| 2013 |
Romond EH, Rastogi P, Jeong JH. Reply to V. Pitini et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2225. PMID 23901419 DOI: 10.1200/Jco.2012.48.3701 |
0.376 |
|
| 2013 |
Shi H, Cheng Y, Jeong JH. Constrained parametric model for simultaneous inference of two cumulative incidence functions. Biometrical Journal. Biometrische Zeitschrift. 55: 82-96. PMID 23090878 DOI: 10.1002/Bimj.201200011 |
0.446 |
|
| 2013 |
Jeong JH, Fine JP. Nonparametric inference on cause-specific quantile residual life. Biometrical Journal. Biometrische Zeitschrift. 55: 68-81. PMID 23065930 DOI: 10.1002/Bimj.201100190 |
0.324 |
|
| 2013 |
Fehrenbacher L, Jeong J, Rastogi P, Geyer CE, Paik S, Ganz PA, Land SR, Costantino JP, Swain SM, Mamounas EP, Wolmark N. NSABP B-47: A randomized phase III trial of adjuvant therapy comparing chemotherapy alone to chemotherapy plus trastuzumab in women with node-positive or high-risk node-negative HER2-low invasive breast cancer. Journal of Clinical Oncology. 31: TPS1139-TPS1139. DOI: 10.1200/Jco.2013.31.15_Suppl.Tps1139 |
0.393 |
|
| 2012 |
Tang G, Paik S, Baehner FL, Liu Q, Jeong JH, Kim SR, Butler SM, Jamshidian F, Cherbavaz DB, Shak S, Julian TB, Lembersky BC, Wickerham DL, Costantino JP, Wolmark N. Prognostic impact of the 21-gene recurrence score (RS) on disease-free and overall survival of node-positive, ER-positive breast cancer patients (pts) treated with adjuvant chemotherapy: Results from NSABP B-28. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1. PMID 28146698 DOI: 10.1200/Jco.2012.30.27_Suppl.1 |
0.339 |
|
| 2012 |
Jeong JH, Lim SM, Yun JY, Rhee GW, Lim JY, Cho JY, Kim YR. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer. Oncology. 83: 292-9. PMID 22964877 DOI: 10.1159/000342376 |
0.468 |
|
| 2012 |
Mell LK, Lau SK, Rose BS, Jeong JH. Reporting of cause-specific treatment effects in cancer clinical trials with competing risks: a systematic review. Contemporary Clinical Trials. 33: 920-4. PMID 22664646 DOI: 10.1016/J.Cct.2012.05.013 |
0.381 |
|
| 2012 |
Park T, Jeong JH, Lee JW. Bayesian nonparametric inference on quantile residual life function: Application to breast cancer data. Statistics in Medicine. 31: 1972-85. PMID 22437758 DOI: 10.1002/Sim.5353 |
0.336 |
|
| 2012 |
Kim MO, Zhou M, Jeong JH. Censored quantile regression for residual lifetimes. Lifetime Data Analysis. 18: 177-94. PMID 22183141 DOI: 10.1007/S10985-011-9212-2 |
0.397 |
|
| 2012 |
Fehrenbacher L, Jeong J, Rastogi P, Geyer CE, Paik S, Ganz PA, Land SR, Costantino JP, Swain SM, Mamounas EP, Wolmark N. NSABP B-47: A phase III trial of adjuvant therapy comparing chemotherapy alone (six cycles of docetaxel plus cyclophosphamide or four cycles of doxorubicin plus cyclophosphamide followed by weekly paclitaxel) to chemotherapy plus trastuzumab in women with node-positive or high-risk, node-negative, HER2-low invasive breast cancer. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.Tps1142 |
0.418 |
|
| 2012 |
Mamounas EP, Tang G, Paik S, Baehner FL, Liu Q, Jeong J, Kim S, Butler SM, Jamshidian F, Cherbavaz DB, Sing AP, Shak S, Julian TB, Lembersky BC, Wickerham DL, et al. Abstract P6-07-01: Prognostic impact of the 21-gene Recurrence Score (RS) on loco-regional recurrence (LRR) of node-positive, ER-positive breast cancer patients (pts) treated with adjuvant chemotherapy: Results from NSABP B-28 Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P6-07-01 |
0.366 |
|
| 2011 |
Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. Population-based study of competing mortality in head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3503-9. PMID 21844503 DOI: 10.1200/Jco.2011.35.7301 |
0.315 |
|
| 2011 |
Zhou M, Jeong JH. Empirical likelihood ratio test for median and mean residual lifetime. Statistics in Medicine. 30: 152-9. PMID 21204121 DOI: 10.1002/Sim.4110 |
0.33 |
|
| 2010 |
Swain SM, Jeong JH, Wolmark N. Amenorrhea from breast cancer therapy--not a matter of dose. The New England Journal of Medicine. 363: 2268-70. PMID 21121855 DOI: 10.1056/Nejmc1009616 |
0.361 |
|
| 2010 |
Mell LK, Jeong JH, Nichols MA, Polite BN, Weichselbaum RR, Chmura SJ. Predictors of competing mortality in early breast cancer. Cancer. 116: 5365-73. PMID 20737562 DOI: 10.1002/Cncr.25370 |
0.411 |
|
| 2010 |
Mell LK, Jeong JH. Pitfalls of using composite primary end points in the presence of competing risks. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4297-9. PMID 20713860 DOI: 10.1200/Jco.2010.30.2802 |
0.381 |
|
| 2010 |
Swain SM, Jeong JH, Geyer CE, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, Rastogi P, Livingston RB, Perez EA, Mamounas EP, Land SR, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. The New England Journal of Medicine. 362: 2053-65. PMID 20519679 DOI: 10.1097/Ogx.0B013E318202211D |
0.39 |
|
| 2010 |
Choi BY, Kim H, Go UY, Jeong J, Lee JW. Comparison of various statistical methods for detecting disease outbreaks Computational Statistics. 25: 603-617. DOI: 10.1007/S00180-010-0191-7 |
0.333 |
|
| 2009 |
Yang SX, Costantino JP, Nguyen D, Jeong J, Mamounas EP, Wolmark N, Kim C, Kidwell K, Paik S, Swain SM. Correlation of levels of Akt phosphorylation at Ser473 with benefit from paclitaxel chemotherapy in NSABP B-28 patients with node-positive breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 537. PMID 27960687 DOI: 10.1200/Jco.2009.27.15_Suppl.537 |
0.399 |
|
| 2009 |
Pusztai L, Jeong JH, Gong Y, Ross JS, Kim C, Paik S, Rouzier R, Andre F, Hortobagyi GN, Wolmark N, Symmans WF. Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4287-92. PMID 19667268 DOI: 10.1200/JCO.2008.21.6887 |
0.401 |
|
| 2009 |
Jung SH, Jeong JH, Bandos H. Regression on quantile residual life. Biometrics. 65: 1203-12. PMID 19432781 DOI: 10.1111/J.1541-0420.2009.01196.X |
0.416 |
|
| 2009 |
Wahed AS, Luong TM, Jeong JH. A new generalization of Weibull distribution with application to a breast cancer data set. Statistics in Medicine. 28: 2077-94. PMID 19424958 DOI: 10.1002/Sim.3598 |
0.402 |
|
| 2009 |
Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, Geyer CE, Wickerham DL, Costantino JP, Wolmark N. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2466-73. PMID 19349544 DOI: 10.1200/Jco.2008.19.8424 |
0.411 |
|
| 2009 |
Jeong J, Lee S. A note on the asymptotic relative efficiency of estimators from the additive hazards model Journal of Statistical Planning and Inference. 139: 4231-4239. DOI: 10.1016/J.Jspi.2009.05.044 |
0.36 |
|
| 2008 |
Jeong JH. Statistical analysis in cancer clinical trials. Anti-Cancer Drugs. 19: S9-10. PMID 18340243 DOI: 10.1097/01.Cad.0000277609.31000.10 |
0.415 |
|
| 2008 |
Jeong JH, Jung SH, Costantino JP. Nonparametric inference on median residual life function. Biometrics. 64: 157-63. PMID 17501936 DOI: 10.1111/J.1541-0420.2007.00826.X |
0.453 |
|
| 2007 |
Jeong JH, Fine JP. Parametric regression on cumulative incidence function. Biostatistics (Oxford, England). 8: 184-96. PMID 16636138 DOI: 10.1093/Biostatistics/Kxj040 |
0.324 |
|
| 2007 |
Dignam JJ, Dukic VM, Anderson SJ, Mamounas EP, Jeong JH, Costantino JP. Time-dependent patterns of recurrence after early stage breast cancer: Preliminary observations and methodological issues Journal of Clinical Oncology. 25: 536-536. DOI: 10.1200/jco.2007.25.18_suppl.536 |
0.336 |
|
| 2007 |
Perez EA, Romond EH, Suman VJ, Jeong J, Davidson NE, Geyer CE, Martino S, Mamounas EP, Kauffman PA, Wolmark N, Ncctg, Nsabp. Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer Journal of Clinical Oncology. 25: 512-512. DOI: 10.1200/Jco.2007.25.18_Suppl.512 |
0.433 |
|
| 2007 |
Paik S, Kim C, Jeong J, Geyer CE, Romond EH, Mejia-Mejia O, Mamounas EP, Wickerham D, Costantino JP, Wolmark N. Benefit from adjuvant trastuzumab may not be confined to patients with IHC 3+ and/or FISH-positive tumors: Central testing results from NSABP B-31 Journal of Clinical Oncology. 25: 511-511. DOI: 10.1200/Jco.2007.25.18_Suppl.511 |
0.358 |
|
| 2007 |
Anderson SJ, Bryant JL, Jeong J, Tang G, Costantino JP, Mamounas E, Geyer CE, Wolmark N. Rethinking the role of nodal status in TNM staging of node-positive breast cancer Journal of Clinical Oncology. 25: 10584-10584. DOI: 10.1200/Jco.2007.25.18_Suppl.10584 |
0.361 |
|
| 2006 |
Taghian AG, Jeong JH, Mamounas EP, Parda DS, Deutsch M, Costantino JP, Wolmark N. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3927-32. PMID 16921044 DOI: 10.1200/Jco.2006.06.9054 |
0.381 |
|
| 2006 |
Jeong JH, Costantino JP. Application of smoothing methods to evaluate treatment-prognostic factor interactions in breast cancer data. Cancer Investigation. 24: 288-93. PMID 16809157 DOI: 10.1080/07357900600633841 |
0.373 |
|
| 2006 |
Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE, Jeong JH, Tan-Chiu E, Fisher B, Wolmark N. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2028-37. PMID 16648502 DOI: 10.1200/Jco.2005.04.3273 |
0.424 |
|
| 2006 |
Jeong JH, Jung SH. Rank tests for clustered survival data when dependent subunits are randomized. Statistics in Medicine. 25: 361-73. PMID 16158408 DOI: 10.1002/Sim.2218 |
0.374 |
|
| 2006 |
Rastogi P, Jeong J, Geyer CE, Costantino JP, Romond EH, Ewer MS, Keefe DL, Levine T, Swain SM, Wolmark N. Five year update of cardiac dysfunction on NSABP B-31, a randomized trial of sequential doxorubicin/cyclophosphamide (AC)->paclitaxel (T) vs. AC->T with trastuzumab (H) Journal of Clinical Oncology. 24: 581-581. DOI: 10.1200/Jco.2007.25.18_Suppl.Lba513 |
0.364 |
|
| 2006 |
Jeong J, Fine J. Direct parametric inference for the cumulative incidence function Journal of the Royal Statistical Society: Series C (Applied Statistics). 55: 187-200. DOI: 10.1111/J.1467-9876.2006.00532.X |
0.34 |
|
| 2006 |
Jeong JH. A new parametric family for modelling cumulative incidence functions: Application to breast cancer data Journal of the Royal Statistical Society. Series a: Statistics in Society. 169: 289-303. DOI: 10.1111/J.1467-985X.2006.00409.X |
0.432 |
|
| 2005 |
Jeong JH, Oakes D. Effects of different hazard ratios on asymptotic relative efficiency of estimates from Cox's model Communications in Statistics - Theory and Methods. 34: 429-448. DOI: 10.1080/03610920509342431 |
0.342 |
|
| 2004 |
Fisher B, Jeong JH, Anderson S, Wolmark N. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. Journal of the National Cancer Institute. 96: 1823-31. PMID 15601638 DOI: 10.1093/Jnci/Djh338 |
0.401 |
|
| 2004 |
Taghian A, Jeong JH, Mamounas E, Anderson S, Bryant J, Deutsch M, Wolmark N. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4247-54. PMID 15452182 DOI: 10.1200/Jco.2004.01.042 |
0.389 |
|
| 2004 |
Fisher B, Jeong JH, Bryant J, Anderson S, Dignam J, Fisher ER, Wolmark N. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet (London, England). 364: 858-68. PMID 15351193 DOI: 10.1016/S0140-6736(04)16981-X |
0.377 |
|
| 2003 |
Jung SH, Jeong JH. Rank tests for clustered survival data. Lifetime Data Analysis. 9: 21-33. PMID 12602772 DOI: 10.1023/A:1021869803601 |
0.368 |
|
| 2003 |
Jeong JH, Jung SH, Wieand S. A parametric model for long-term follow-up data from phase III breast cancer clinical trials. Statistics in Medicine. 22: 339-52. PMID 12529867 DOI: 10.1002/Sim.1349 |
0.452 |
|
| 2003 |
Jeong JH. Efficiency of log-rank test under dependent censorship Communications in Statistics - Theory and Methods. 32: 1197-1211. DOI: 10.1081/Sta-120021327 |
0.317 |
|
| 2002 |
Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. The New England Journal of Medicine. 347: 567-75. PMID 12192016 DOI: 10.1056/Nejmoa020128 |
0.34 |
|
| 2001 |
Jeong J. A NOTE ON ASYMPTOTIC EFFICIENCY OF A REGRESSION COEFFICIENT PARAMETER UNDER ORDINAL LOGISTIC REGRESSION MODEL Communications in Statistics - Theory and Methods. 30: 1257-1269. DOI: 10.1081/Sta-100104744 |
0.334 |
|
| 1998 |
Oakes D, Jeong JH. Frailty Models and Rank Tests Lifetime Data Analysis. 4: 209-228. PMID 9787603 DOI: 10.1023/A:1009689630516 |
0.332 |
|
| Show low-probability matches. |